DNA vs. ARDX
Compare and contrast key facts about Ginkgo Bioworks Holdings, Inc. (DNA) and Ardelyx, Inc. (ARDX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DNA or ARDX.
Correlation
The correlation between DNA and ARDX is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DNA vs. ARDX - Performance Comparison
Key characteristics
DNA:
-0.79
ARDX:
-0.46
DNA:
-1.75
ARDX:
-0.23
DNA:
0.82
ARDX:
0.97
DNA:
-0.87
ARDX:
-0.41
DNA:
-1.19
ARDX:
-0.97
DNA:
72.38%
ARDX:
36.59%
DNA:
110.10%
ARDX:
77.38%
DNA:
-99.10%
ARDX:
-98.45%
DNA:
-99.04%
ARDX:
-85.59%
Fundamentals
DNA:
$328.47M
ARDX:
$1.16B
DNA:
-$10.54
ARDX:
-$0.17
DNA:
$189.10M
ARDX:
$287.59M
DNA:
$138.44M
ARDX:
$243.60M
DNA:
-$316.36M
ARDX:
$5.19M
Returns By Period
In the year-to-date period, DNA achieves a -41.96% return, which is significantly lower than ARDX's -6.51% return.
DNA
-41.96%
-29.80%
-29.80%
-86.93%
N/A
N/A
ARDX
-6.51%
-12.38%
-28.83%
-35.51%
-3.80%
-9.40%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DNA vs. ARDX — Risk-Adjusted Performance Rank
DNA
ARDX
DNA vs. ARDX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Ginkgo Bioworks Holdings, Inc. (DNA) and Ardelyx, Inc. (ARDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DNA vs. ARDX - Dividend Comparison
Neither DNA nor ARDX has paid dividends to shareholders.
Drawdowns
DNA vs. ARDX - Drawdown Comparison
The maximum DNA drawdown since its inception was -99.10%, roughly equal to the maximum ARDX drawdown of -98.45%. Use the drawdown chart below to compare losses from any high point for DNA and ARDX. For additional features, visit the drawdowns tool.
Volatility
DNA vs. ARDX - Volatility Comparison
Ginkgo Bioworks Holdings, Inc. (DNA) has a higher volatility of 25.33% compared to Ardelyx, Inc. (ARDX) at 13.31%. This indicates that DNA's price experiences larger fluctuations and is considered to be riskier than ARDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DNA vs. ARDX - Financials Comparison
This section allows you to compare key financial metrics between Ginkgo Bioworks Holdings, Inc. and Ardelyx, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities